U.S. markets open in 3 hours 46 minutes

Foresight Acquisition Corp. (FORE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
9.860.00 (0.00%)
At close: 3:16PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close9.86
Open9.85
Bid9.84 x 4000
Ask9.87 x 1000
Day's Range9.85 - 9.86
52 Week Range9.63 - 10.00
Volume119,766
Avg. Volume164,282
Market Cap397.981M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Foresight Acquisition Corp.
    Analyst Report: United Therapeutics CorpUnited Therapeutics is a biotechnology company focused on the development and commercialization of therapeutic products for patients with cardiovascular conditions, cancer and infectious diseases. It has five approved products on the market and a strong new product pipeline. The company has roughly 950 employees and is a component of the S&P 400.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more